Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Fares Alsawah, MD BS, MS, Samuel A. Merrill, MD PhD, Paula L. Bockenstedt, MD, Erica L. Campagnaro, MD, Sumana Devata, MD, Scott D. Gitlin, MD, Mark S Kaminski, MD, Alice M. Cusick, MD, Tycel J. Phillips, MD, Suman L. Sood, MD, Moshe Talpaz, MD, Albert Thomas Quiery, MD, Philip S Boonstra, PhD, Asra Z. Ahmed, MD, Ryan A. Wilcox, MD PhD

Blood (2018) 132 (Supplement 1): 1119.

https://doi.org/10.1182/blood-2018-99-116854

Published: 2018

Journal Articles

Determinants of Hematology-Oncology Trainee's Post-Fellowship Career Pathways with a Focus on Non-Malignant Hematology

Ariela L. Marshall, MD, Sarah Jenkins, MS, Joseph Mikhael, MD MD FRCPC, Scott D. Gitlin, MD

Blood (2017) 130 (Supplement 1): 3365.

https://doi.org/10.1182/blood.V130.Suppl_1.3365.3365

Published: 2017

Journal Articles

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Linda J Burns, MD, Charles P Clayton, James N. George, MD, Beverly S. Mitchell, Scott D. Gitlin, MD

Blood (2013) 122 (21): 1679.

https://doi.org/10.1182/blood.V122.21.1679.1679

Published: 2013

Journal Articles

Role of Human Endogenous Retroviruses in Lymphoma Pathogenesis and a Possible Biomarker of Disease

Scott D. Gitlin, MD, Rafael Contreras- Galindo, Mark H. Kaplan, David M. Markovitz

Blood (2008) 112 (11): 3751.

https://doi.org/10.1182/blood.V112.11.3751.3751

Published: 2008

Journal Articles

Functional Interactions of Ets1 with Viral and Cellular Proteins Mediate Ets1’s Effects on Transcription and the Pathogenesis of Adult T-Cell Leukemia/Lymphoma.

Scott D. Gitlin, MD, Matthew D. Morse

Blood (2005) 106 (11): 2608.

https://doi.org/10.1182/blood.V106.11.2608.2608

Published: 2005

NARROW

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Determinants of Hematology-Oncology Trainee's Post-Fellowship Career Pathways with a Focus on Non-Malignant Hematology

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Role of Human Endogenous Retroviruses in Lymphoma Pathogenesis and a Possible Biomarker of Disease

Functional Interactions of Ets1 with Viral and Cellular Proteins Mediate Ets1’s Effects on Transcription and the Pathogenesis of Adult T-Cell Leukemia/Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Determinants of Hematology-Oncology Trainee's Post-Fellowship Career Pathways with a Focus on Non-Malignant Hematology

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Role of Human Endogenous Retroviruses in Lymphoma Pathogenesis and a Possible Biomarker of Disease

Functional Interactions of Ets1 with Viral and Cellular Proteins Mediate Ets1’s Effects on Transcription and the Pathogenesis of Adult T-Cell Leukemia/Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only